Comparing Newer Drug-Eluting Stents for Narrowed Heart Arteries in Routine Care
Compares new drug-eluting stents with older versions in adults with coronary artery disease.
Plain-language title generated from the registry record
Registry title: Evaluation of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
Key facts
- Where
- Multiple Locations, South KoreaSee the site
Where in South Korea
- Korean centresMultiple Locations, South KoreaTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Seung-Jung Park
- Trial code
- NCT01186133
- Record updated
- 30 June 2026
- Original description
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.Read full original descriptionShow less
Evaluation of Effectiveness and Safety of the First, Second, and New Drug-Eluting Stents in Routine Clinical Practice
The objective of this study is to evaluate effectiveness and safety of the new drug-eluting stent (DES), as compared with the first-,second-,third-, and fourth-generation DES, in the "real world" daily practice.
Inclusion: coronary disease amenable to percutaneous coronary intervention (PCI); no clinical and lesion limitations.
Exclusion: terminal illness with life expectancy less than 1 year; patients with a mixture of several DES; patients with cardiogenic shock.